john-michael sauer - how does pstc play into drug development?
Published 4 years ago • 26 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:27
john-michael sauer - what is pstc?
-
0:38
john-michael sauer - how can biomarkers be used in drug development?
-
2:18
pstc 15 years: how has pstc impact drug development?
-
0:32
john-michael sauer - what are biomarkers?
-
0:37
john-michael sauer - tell us about your class
-
1:00
john-michael sauer - what makes c-path so unique?
-
1:21
john-michael sauer - what is the biomarker data repository?
-
0:48
john-michael sauer - what makes c-path's biomarker program so special?
-
41:30
collapse of the microbiome, emergence of the pathobiome, and the immunopathology of critical illness
-
19:30
overview of the cmt drug development pipeline
-
9:13
an overview of clinical trials
-
1:06
john-michael sauer - more on c-path's biomarker program
-
1:28
john-michael sauer - regulatory science certificate collaboration with university of arizona
-
1:04
john-michael sauer - what diseases do we have biomarker programs for?
-
7:14
pstc 2021 workshop: keynote video: jon mirsalis
-
2:47
pstc 2021 workshop: welcome
-
36:48
pstc 2021 workshop: the power of collaboration
-
21:05
pstc 2021 workshop: the importance of pstc to industry
-
42:53
pstc 2021 workshop: q&a panel discussion